Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    66.7%

    Based on 2 completed trials

    Completion Rate
    67%(2/3)
    Active Trials
    0(0%)
    Results Posted
    100%(2 trials)
    Terminated
    1(20%)

    Phase Distribution

    Phase 2
    4
    80%
    Not Applicable
    1
    20%

    Phase Distribution

    0

    Early Stage

    4

    Mid Stage

    0

    Late Stage

    Phase Distribution5 total trials
    Phase 2Efficacy & side effects
    4(80.0%)
    N/ANon-phased studies
    1(20.0%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    66.7%

    2 of 3 finished

    Non-Completion Rate

    33.3%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    5

    all time

    Status Distribution
    Completed(2)
    Terminated(1)
    Other(2)

    Detailed Status

    Completed2
    Terminated1
    unknown1
    Suspended1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    5
    Active
    0
    Success Rate
    66.7%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 24 (80.0%)
    N/A1 (20.0%)

    Trials by Status

    terminated120%
    unknown120%
    completed240%
    suspended120%

    Recent Activity

    0 active trials
    Showing 5 of 5
    completedphase_2

    A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor

    NCT04937920
    terminatedphase_2

    Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

    NCT05253755
    suspendedphase_2

    A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis

    NCT05491603
    unknownphase_2

    A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis

    NCT05493488
    completednot_applicable

    Ocular Surface Disorders in Patients in Intensive Care Units, a Comparative Study of Three Preventive Approaches

    NCT02348242

    Clinical Trials (5)

    Showing 5 of 5 trials
    NCT04937920Phase 2

    A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor

    Completed
    NCT05253755Phase 2

    Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

    Terminated
    NCT05491603Phase 2

    A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis

    Suspended
    NCT05493488Phase 2

    A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis

    Unknown
    NCT02348242Not Applicable

    Ocular Surface Disorders in Patients in Intensive Care Units, a Comparative Study of Three Preventive Approaches

    Completed

    All 5 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    5